Ampullary adenoma treated by endoscopic double-snare retracting papillectomy

Hiromitsu Soma, Naoteru Miyata, Shigenari Hozawa, Hajime Higuchi, Yoshiyuki Yamagishi, Yuji Nakamura, Keita Saeki, Kaori Kameyama, Yohei Masugi, Naohisa Yahagi, Takanori Kanai

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

We report herein improved methods for the safe and successful completion of endoscopic papillectomy (EP). Between January 2008 and November 2011, 12 patients underwent double-snare retracting papillectomy for the treatment of lesions of the major duodenal papilla. The main outcomes were en bloc resection rates, pathological findings, and adverse events. All of the patients (mean age, 60.1 years; range, 38 to 80 years) were diagnosed with ampullary adenoma by endoscopic forceps biopsies prior to endoscopic snare papillectomy. En bloc resection by double-snare retracting papillectomy was successfully performed for all lesions (median size, 12.3 mm), comprising six tubular adenomas, one tubulovillous adenoma, three cases of epithelial atypia, one hamartomatous polyp, and one case of duodenitis with regenerative change. Significant hemorrhage and pancreatitis were observed in one case after EP. Adenoma recurrence occurred in three patients during follow-up (median, 28.5 months) at a mean interval of 2 months postoperatively (range, 1 to 3 months). No serious adverse events were observed. Double-snare retracting papillectomy is effective and feasible for treating lesions of the major duodenal papilla. Further treatment experience, including a single-arm phase II study, needs to be accumulated before conducting a randomized controlled study.

Original languageEnglish
Pages (from-to)689-692
Number of pages4
JournalGut and Liver
Volume9
Issue number5
DOIs
Publication statusPublished - 2015 Sep 1

Fingerprint

Adenoma
Ampulla of Vater
Duodenitis
Polyps
Surgical Instruments
Pancreatitis
Hemorrhage
Biopsy
Recurrence
Therapeutics

Keywords

  • Argon plasma coagulation
  • Endoscopic papillectomy
  • Endosonography
  • Intraductal ultrasonography
  • Tubular adenoma

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

Ampullary adenoma treated by endoscopic double-snare retracting papillectomy. / Soma, Hiromitsu; Miyata, Naoteru; Hozawa, Shigenari; Higuchi, Hajime; Yamagishi, Yoshiyuki; Nakamura, Yuji; Saeki, Keita; Kameyama, Kaori; Masugi, Yohei; Yahagi, Naohisa; Kanai, Takanori.

In: Gut and Liver, Vol. 9, No. 5, 01.09.2015, p. 689-692.

Research output: Contribution to journalArticle

Soma H, Miyata N, Hozawa S, Higuchi H, Yamagishi Y, Nakamura Y et al. Ampullary adenoma treated by endoscopic double-snare retracting papillectomy. Gut and Liver. 2015 Sep 1;9(5):689-692. https://doi.org/10.5009/gnl14206
Soma, Hiromitsu ; Miyata, Naoteru ; Hozawa, Shigenari ; Higuchi, Hajime ; Yamagishi, Yoshiyuki ; Nakamura, Yuji ; Saeki, Keita ; Kameyama, Kaori ; Masugi, Yohei ; Yahagi, Naohisa ; Kanai, Takanori. / Ampullary adenoma treated by endoscopic double-snare retracting papillectomy. In: Gut and Liver. 2015 ; Vol. 9, No. 5. pp. 689-692.
@article{11ef3a6d14f548fbbffcf5fe500d620c,
title = "Ampullary adenoma treated by endoscopic double-snare retracting papillectomy",
abstract = "We report herein improved methods for the safe and successful completion of endoscopic papillectomy (EP). Between January 2008 and November 2011, 12 patients underwent double-snare retracting papillectomy for the treatment of lesions of the major duodenal papilla. The main outcomes were en bloc resection rates, pathological findings, and adverse events. All of the patients (mean age, 60.1 years; range, 38 to 80 years) were diagnosed with ampullary adenoma by endoscopic forceps biopsies prior to endoscopic snare papillectomy. En bloc resection by double-snare retracting papillectomy was successfully performed for all lesions (median size, 12.3 mm), comprising six tubular adenomas, one tubulovillous adenoma, three cases of epithelial atypia, one hamartomatous polyp, and one case of duodenitis with regenerative change. Significant hemorrhage and pancreatitis were observed in one case after EP. Adenoma recurrence occurred in three patients during follow-up (median, 28.5 months) at a mean interval of 2 months postoperatively (range, 1 to 3 months). No serious adverse events were observed. Double-snare retracting papillectomy is effective and feasible for treating lesions of the major duodenal papilla. Further treatment experience, including a single-arm phase II study, needs to be accumulated before conducting a randomized controlled study.",
keywords = "Argon plasma coagulation, Endoscopic papillectomy, Endosonography, Intraductal ultrasonography, Tubular adenoma",
author = "Hiromitsu Soma and Naoteru Miyata and Shigenari Hozawa and Hajime Higuchi and Yoshiyuki Yamagishi and Yuji Nakamura and Keita Saeki and Kaori Kameyama and Yohei Masugi and Naohisa Yahagi and Takanori Kanai",
year = "2015",
month = "9",
day = "1",
doi = "10.5009/gnl14206",
language = "English",
volume = "9",
pages = "689--692",
journal = "Gut and Liver",
issn = "1976-2283",
publisher = "Joe Bok Chung",
number = "5",

}

TY - JOUR

T1 - Ampullary adenoma treated by endoscopic double-snare retracting papillectomy

AU - Soma, Hiromitsu

AU - Miyata, Naoteru

AU - Hozawa, Shigenari

AU - Higuchi, Hajime

AU - Yamagishi, Yoshiyuki

AU - Nakamura, Yuji

AU - Saeki, Keita

AU - Kameyama, Kaori

AU - Masugi, Yohei

AU - Yahagi, Naohisa

AU - Kanai, Takanori

PY - 2015/9/1

Y1 - 2015/9/1

N2 - We report herein improved methods for the safe and successful completion of endoscopic papillectomy (EP). Between January 2008 and November 2011, 12 patients underwent double-snare retracting papillectomy for the treatment of lesions of the major duodenal papilla. The main outcomes were en bloc resection rates, pathological findings, and adverse events. All of the patients (mean age, 60.1 years; range, 38 to 80 years) were diagnosed with ampullary adenoma by endoscopic forceps biopsies prior to endoscopic snare papillectomy. En bloc resection by double-snare retracting papillectomy was successfully performed for all lesions (median size, 12.3 mm), comprising six tubular adenomas, one tubulovillous adenoma, three cases of epithelial atypia, one hamartomatous polyp, and one case of duodenitis with regenerative change. Significant hemorrhage and pancreatitis were observed in one case after EP. Adenoma recurrence occurred in three patients during follow-up (median, 28.5 months) at a mean interval of 2 months postoperatively (range, 1 to 3 months). No serious adverse events were observed. Double-snare retracting papillectomy is effective and feasible for treating lesions of the major duodenal papilla. Further treatment experience, including a single-arm phase II study, needs to be accumulated before conducting a randomized controlled study.

AB - We report herein improved methods for the safe and successful completion of endoscopic papillectomy (EP). Between January 2008 and November 2011, 12 patients underwent double-snare retracting papillectomy for the treatment of lesions of the major duodenal papilla. The main outcomes were en bloc resection rates, pathological findings, and adverse events. All of the patients (mean age, 60.1 years; range, 38 to 80 years) were diagnosed with ampullary adenoma by endoscopic forceps biopsies prior to endoscopic snare papillectomy. En bloc resection by double-snare retracting papillectomy was successfully performed for all lesions (median size, 12.3 mm), comprising six tubular adenomas, one tubulovillous adenoma, three cases of epithelial atypia, one hamartomatous polyp, and one case of duodenitis with regenerative change. Significant hemorrhage and pancreatitis were observed in one case after EP. Adenoma recurrence occurred in three patients during follow-up (median, 28.5 months) at a mean interval of 2 months postoperatively (range, 1 to 3 months). No serious adverse events were observed. Double-snare retracting papillectomy is effective and feasible for treating lesions of the major duodenal papilla. Further treatment experience, including a single-arm phase II study, needs to be accumulated before conducting a randomized controlled study.

KW - Argon plasma coagulation

KW - Endoscopic papillectomy

KW - Endosonography

KW - Intraductal ultrasonography

KW - Tubular adenoma

UR - http://www.scopus.com/inward/record.url?scp=84942110346&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942110346&partnerID=8YFLogxK

U2 - 10.5009/gnl14206

DO - 10.5009/gnl14206

M3 - Article

C2 - 26087781

AN - SCOPUS:84942110346

VL - 9

SP - 689

EP - 692

JO - Gut and Liver

JF - Gut and Liver

SN - 1976-2283

IS - 5

ER -